Table of Contents
ALLEGAN, Mich. - Perrigo's Opill, the first over-the-counter daily birth control pill in the U.S., has partnered with WNBA star Napheesa Collier, an Olympic Gold Medalist and starting forward for the Minnesota Lynx, to raise awareness about accessible reproductive healthcare. This collaboration builds on Opill's existing relationship with the Women's National Basketball Association (WNBA) and aims to engage women in discussions about their birth control options.
Collier, a strong advocate for women's health, sees this initiative as vital for empowering women to understand their healthcare choices. As part of her role, she will participate in campus events nationwide to promote safe and affordable contraception. With many women expressing interest in non-prescription options, Opill aims to provide convenient solutions for those struggling to access birth control.
"It is important, especially now, to talk to women about their options when it comes to reproductive health," said Collier. "I am ready to get out there and have these very important conversations and to help women learn about accessing the birth control that's right for them, including Opill."
The partnership emphasizes the growing importance of over-the-counter healthcare options. Leia Bahbah, Perrigo's U.S. Women's Health Brand Lead, noted that the collaboration aligns with the WNBA's mission to support women's health education.
"One of the reasons Opill partnered with the WNBA is because the players are so passionate about using their platform to champion causes they believe in," said Leila Bahbah, Perrigo U.S. Women's Health Brand Lead. "Napheesa exudes that passion, and together, we plan to educate and empower people to take charge of their reproductive health."
